Persistent URL of this record https://hdl.handle.net/1887/100084
In Collections
This item can be found in the following collections:
![Time course of adverse events in the phase III GRID study of regorafenib in patients with metastatic gastrointestinal stromal tumors (GIST)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Time course of adverse events in the phase III GRID study of regorafenib in patients with metastatic gastrointestinal stromal tumors (GIST)
- All authors
- Bauer, S.; Blay, J.Y.; Casali, P.G.; Reichardt, P.; Kang, Y.K.; Rutkowski, P.; Gelderblom, H.; Hohenberger, P.; Kappeler, C.; Kuss, I.; Demetri, G.D.
- Date
- 2013-09-30
- Journal
- European Journal of Cancer
- Volume
- 49
- Pages
- S884 - S885